| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC1578 |
| Trial ID | NCT02649582 |
| Disease | Brain Glioblastoma Multiforme |
| Altered gene | WT1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | WT1-RNA DC Vaccine |
| Co-treatment | temozolomide |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Adjuvant Dendritic-Cell Immunotherapy Plus Temozolomide Following Surgery and Chemoradiation in Patients With Newly Diagnosed Glioblastoma |
| Year | 2015 |
| Country | Belgium |
| Company sponsor | University Hospital, Antwerp |
| Other ID(s) | CCRG14-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||